Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ciba Voltaren-XR to cost $2.32 per day AWP; once-daily diclofenac available April 11.

Executive Summary

CIBA VOLTAREN-XR TO BE LAUNCHED APRIL 11 AT $2.32 PER DAY AWP, placing the once-daily formulation of diclofenac sodium in the mid-range of costs for treating arthritis with older diclofenac formulations. Voltaren-XR will cost $232 for 100-count 100 mg tablet bottles. Diclofenac sodium extended-release tablets for chronic therapy of osteoarthritis and rheumatoid arthritis were approved March 8 ("The Pink Sheet" March 18, T&G-1).
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027946

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel